Michael John Rance
Directeur/Membre du Conseil chez MNLpharma Ltd.
Profil
Michael John Rance is a Non-Executive Director at MNLpharma Ltd.
since 2005.
He previously held positions as a Non-Executive Director at Medical Marketing International Group Plc, Vice President-Corporate Affairs at AstraZeneca PLC, and Principal at Reckitt & Colman Plc and AstraZeneca, Inc.
Postes actifs de Michael John Rance
| Sociétés | Poste | Début |
|---|---|---|
MNLpharma Ltd.
 MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Directeur/Membre du Conseil | 21/02/2005 |
Anciens postes connus de Michael John Rance
| Sociétés | Poste | Fin |
|---|---|---|
Medical Marketing International Group Plc
 Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 19/09/2007 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
| Reckitt & Colman Plc | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Health Services |
| Reckitt & Colman Plc | Commercial Services |
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
